Unique ID issued by UMIN | UMIN000031679 |
---|---|
Receipt number | R000036183 |
Scientific Title | Effect of Probiotic Intake on Improvement of Higher Cerebral Function in Participants with Suspected Mild Cognitive Impairment |
Date of disclosure of the study information | 2018/04/04 |
Last modified on | 2018/10/29 12:34:30 |
Effect of Probiotic Intake on Improvement of Higher Cerebral Function in Participants with Suspected Mild Cognitive Impairment
Effect of Probiotic on Participants with Suspected Mild Cognitive Impairment
Effect of Probiotic Intake on Improvement of Higher Cerebral Function in Participants with Suspected Mild Cognitive Impairment
Effect of Probiotic on Participants with Suspected Mild Cognitive Impairment
Japan |
Healthy subjects
Adult |
Others
NO
To explore the effect of probiotics supplementation for 12 weeks on brain function in participants who are concerned about forgetfulness.
Efficacy
Confirmatory
Explanatory
RBANS
MMSE
POMS2(Short Form)
Patient Health Questionnaire-9 (PHQ-9)
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
Institution is not considered as adjustment factor.
Central registration
2
Prevention
Food |
12-week intake of the test food
12-week intake of the placebo food
50 | years-old | <= |
80 | years-old | > |
Male and Female
1) Age:50 and over, below 80.
2) Sex:Males and females with Japanese nationality.
3) Subjects whose MMSE score is 22 to 27.
1) Subjects who are under medication or treatment for serious disease.
2) Subjects who are under diet therapy and exercise therapy in the control of doctor.
3) Subjects with a history of liver disease or serious renal, endocrine, cardiovascular, gastrointestinal, pulmonary, hematological and metabolic diseases or those who undertake medication or treatment for such disease.
4) Subjects having a history of major surgery involving gastrectomy, gastrointestinal suture surgery, bowel resection, digestive system etc. (except fo rappendicitis)
5) Subjects with a current or past history of psychiatric disorders.
6) Subjects with a current or past history of drug or food allergy.
7) Subjects who are diagnosed as dementia.
8) Subjects who are receiving or have a history of drug dependence or drug abuse.
9) Subjects who have participated in other clinical tests within the past one months.
10) Subjects with irregular working hours, such as night shifts.
11) Subjects with a current or past history of alcoholism.
12) Subjects who were judged inadequate by investigator for other reasons.
120
1st name | |
Middle name | |
Last name | Matsuoka Masao |
HUMA R&D CORP
Clinical Development Division
OekkusuBldg.10F, 5-31-19 Shiba Minato-ku, Tokyo 108-0014 Japan
03-3431-1260
matsuoka@huma-c.co.jp
1st name | |
Middle name | |
Last name | Matsuoka Masao |
HUMA R&D CORP
Clinical Development Division
Oekkusu Bldg.10F, 5-31-19 Shiba Minato-ku, Tokyo 108-0014 Japan
03-3431-1260
matsuoka@huma-c.co.jp
HUMA R&D CORP
Morinaga Milk Industy Co, Ltd.
Profit organization
Japan
NO
2018 | Year | 04 | Month | 04 | Day |
Unpublished
Completed
2018 | Year | 02 | Month | 08 | Day |
2018 | Year | 03 | Month | 26 | Day |
2018 | Year | 07 | Month | 27 | Day |
2018 | Year | 08 | Month | 10 | Day |
2018 | Year | 08 | Month | 10 | Day |
2018 | Year | 08 | Month | 24 | Day |
2018 | Year | 03 | Month | 12 | Day |
2018 | Year | 10 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036183
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |